These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6141902)

  • 21. Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Yoshida K; Itogawa A; Tagawa M; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1095-102. PubMed ID: 8267676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative theobromine metabolism in five mammalian species.
    Miller GE; Radulovic LL; DeWit RH; Brabec MJ; Tarka SM; Cornish HH
    Drug Metab Dispos; 1984; 12(2):154-60. PubMed ID: 6144479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and structural characterization by spectroscopic methods of two glucuronide metabolites of mexiletine after N-oxidation and deamination.
    Turgeon J; Paré JR; Lalande M; Grech-Bélanger O; Bélanger PM
    Drug Metab Dispos; 1992; 20(5):762-9. PubMed ID: 1358583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification and 1H NMR spectroscopic characterization of phase II metabolites of tolfenamic acid.
    Sidelmann UG; Christiansen E; Krogh L; Cornett C; Tjørnelund J; Hansen SH
    Drug Metab Dispos; 1997 Jun; 25(6):725-31. PubMed ID: 9193874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disposition and metabolism of finasteride in dogs.
    Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ
    Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance.
    Prakash C; Wang W; O'Connell T; Johnson KA
    Drug Metab Dispos; 2008 Oct; 36(10):2093-103. PubMed ID: 18653741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
    Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG
    Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biotransformation of a 1,5-benzodiazepine, triflubazam, by man.
    Alton KB; Grimes RM; Shaw C; Patrick JE; McGuire JL
    Drug Metab Dispos; 1975; 3(5):352-60. PubMed ID: 241616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance.
    Prakash C; Chen W; Rossulek M; Johnson K; Zhang C; O'Connell T; Potchoiba M; Dalvie D
    Drug Metab Dispos; 2008 Oct; 36(10):2064-79. PubMed ID: 18653742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [AR-L 115 BS, comparison of human metabolite pattern and biotransformation with other species].
    Roth W; Prox A; Reuter A; Schmid J; Zimmer A; Zipp H
    Arzneimittelforschung; 1981; 31(1a):232-5. PubMed ID: 7195228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural elucidation of human oxidative metabolites of muraglitazar: use of microbial bioreactors in the biosynthesis of metabolite standards.
    Zhang D; Zhang H; Aranibar N; Hanson R; Huang Y; Cheng PT; Wu S; Bonacorsi S; Zhu M; Swaminathan A; Humphreys WG
    Drug Metab Dispos; 2006 Feb; 34(2):267-80. PubMed ID: 16280454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolites of [(14)C]-5-(2-ethyl-2H-tetrazol-5-yl)-1-methyl-1,2,3, 6-tetrahydropyridine in mice, rats, dogs, and humans.
    Christensen EB; Andersen JB; Pedersen H; Jensen KG; Dalgaard L
    Drug Metab Dispos; 1999 Nov; 27(11):1341-9. PubMed ID: 10534320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxicokinetics and biotransformation of 3-(4-methylbenzylidene)camphor in rats after oral administration.
    Völkel W; Colnot T; Schauer UM; Broschard TH; Dekant W
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):331-8. PubMed ID: 16806338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiological disposition of L-663,581, a partial agonist of the benzodiazepine receptor, in laboratory animals.
    Chen IW; Lin JH
    Drug Metab Dispos; 1994; 22(5):693-9. PubMed ID: 7835219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biotransformation of aza-3-chalcol in the rat: isolation and structural analysis of seven metabolites].
    Morand JM; Cussac M; Kaouadji M; Thomasson F
    Pharm Acta Helv; 1992; 67(12):333-40. PubMed ID: 1488451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.
    Mamidi RN; Mannens G; Annaert P; Hendrickx J; Goris I; Bockx M; Janssen CG; Kao M; Kelley MF; Meuldermans W
    Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regioisomeric aromatic dihydroxylation of propranolol. Use of monohydroxylated intermediates for structural assignments of the metabolites formed in vitro.
    Talaat RE; Nelson WL
    Drug Metab Dispos; 1988; 16(2):207-11. PubMed ID: 2898334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disposition and metabolism of radiolabeled casopitant in humans.
    Pellegatti M; Bordini E; Fizzotti P; Roberts A; Johnson BM
    Drug Metab Dispos; 2009 Aug; 37(8):1635-45. PubMed ID: 19420128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 rats.
    Musser SM; Egorin MJ; Zuhowski EG; Hamburger DR; Parise RA; Covey JM; White KD; Eiseman JL
    Cancer Chemother Pharmacol; 2003 Aug; 52(2):139-46. PubMed ID: 12761648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biotransformation of tolterodine, a new muscarinic receptor antagonist, in mice, rats, and dogs.
    Andersson SH; Lindgren A; Postlind H
    Drug Metab Dispos; 1998 Jun; 26(6):528-35. PubMed ID: 9616187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.